The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670401290) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon designed for the treatment of peripheral arterial disease. This 4 mm diameter by 120 mm length device combines a low-profile balloon platform with the proprietary TransPax drug coating to deliver an antiproliferative therapeutic dose to the vessel wall during dilatation.
Key Features
Paclitaxel drug coating intended to inhibit neointimal hyperplasia
TransPax coating technology engineered for efficient drug transfer with low particulate loss
Balloon diameter 4 mm, balloon length 120 mm
Low-profile balloon design for crossing and tracking in peripheral vasculature
Over-the-wire catheter configuration compatible with standard peripheral guidewires
Radiopaque markers to aid fluoroscopic positioning of the balloon working length
Clinical Applications
Percutaneous transluminal angioplasty of stenotic or occlusive lesions in peripheral arteries
Treatment of lesions in the superficial femoral and popliteal arteries as indicated in the manufacturer IFU
Post-dilatation strategies following recanalization procedures where a drug-coated balloon is selected
Procurement for hospital cath labs, endovascular suites, and office-based labs performing peripheral interventions
Product Information
Brand: Boston Scientific
Product Family: Ranger Drug-Coated Balloon
Category: Peripheral Balloon Catheters
REF/UPN: H74939670401290
Balloon Diameter: 4 mm
Balloon Length: 120 mm
Drug Coating: Paclitaxel (TransPax coating)
Catheter Platform: Over-the-wire PTA balloon catheter
Guidewire Compatibility: Not specified in the located sources
Usable Catheter Length: Not specified in the located sources
Introducer Sheath Compatibility: Not specified in the located sources
Rated Burst Pressure: Not specified in the located sources
Sterilization: Sterile, single-use device
Packaging: Single unit per box per manufacturer configuration